CVE-2014-125081: A vulnerability, which was classified as critical, has been found in risheesh debutsav
CVE-2014-125081 is a medium-severity flaw (CVSS 5.5) affecting debutsav. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
A vulnerability, which was classified as critical, has been found in risheesh debutsav. This issue affects some unknown processing. The manipulation leads to sql injection. The patch is named 7a8430df79277c613449262201cc792db894fc76. It is recommended to apply a patch to fix this issue. The associated identifier of this vulnerability is VDB-218459.
Why this priority
- No elevated risk signals yet
A fixed release or distro patch exists.
Risk facts
| CVSS score | 5.5 (Medium) |
| Attack vector | Adjacent network |
| Attack complexity | Low |
| Privileges needed | Low |
| User interaction | None |
| EPSS exploit chance | 0.8% (top 45%) |
| CISA exploited list | No |
| Weakness | CWE-89 |
| Published | 2023-01-17 |
| Last modified | 2026-06-17 |
Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2014-125081?
debutsav: upgrade to 2014-10-05. Exact commands for each OS are on this page.
Is CVE-2014-125081 being exploited?
CVE-2014-125081 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2014-125081 affect?
CVE-2014-125081 affects debutsav. Severity is medium (CVSS 5.5). A vulnerability, which was classified as critical, has been found in risheesh debutsav. This issue affects some unknown processing. The manipulation leads to sql injection. The patch is named 7a8430df79277c613449262201cc792db894fc76. It is
How urgent is CVE-2014-125081?
Priority 33/100. No elevated risk signals yet.